Press

CHINESE MARKET FOR CARDIOVASCULAR DEVICES FORECAST TO GROW 18% ANNUALLY THROUGH 2013, DRIVEN BY EXPANDED SERVICES AND PROCEDURES

HUNTINGTON BEACH, Calif.-January 21, 2009--(BUSINESS WIRE)--According to a new report, 2009 Opportunities in Chinese Cardiovascular Device Markets, distributed exclusively by Life Science Intelligence (LSI) and published by Health Research International (HRI), the Chinese market for cardiovascular devices will reach $1.37 billion in 2013.

The combination of a large, aging population and strong economic growth has focused significant attention on China as the health care market of the future. Other reports and analyses predict substantial growth for China's medical device markets; however, rarely do they provide hard data regarding epidemiological and procedure trends driving demand, the domestic health delivery system, domestic manufacturing capabilities, and cultural issues impacting medical device utilization. This report fills this gap with a detailed analysis of cardiovascular epidemiology in China; procedure trends; profiles of leading cardiovascular hospitals, physicians, and domestic suppliers; and cultural factors impacting health care in China. In addition, the 244-page report addresses the current and future status of interventional cardiology, cardiac surgery, and rhythm management in China. Nearly 100 exhibits address major procedures and product markets, including: PCI disposables, coronary stents, percutaneous defect repair technologies, cardiopulmonary bypass disposables, prosthetic heart valve products, endovascular aneurysm repair products, advanced electrophysiology systems and catheters, radiofrequency ablation systems and disposables, pacemakers, and implantable cardioverter defibrillators. These exhibits and the market analyses include the results of a major survey of five leading Chinese hospitals regarding their cardiovascular procedures and products.

Immediate access to the Table of Contents for this report is available at: www.lsintelligence.com/market-reports-page.php?id=HRI-0511.

2009 Opportunities in Chinese Cardiovascular Device Markets concludes that two factors will continue to drive developments in China's health care markets through 2013: continued, strict government control of the health delivery system, and continued observation of the Chinese virtue of "patience." Now is the window of opportunity to enter China and participate in both its health care growth and product markets. Even with the constraints identified in this report, cardiovascular product sales are projected to increase 18% annually through 2013, attesting to the significant opportunity in China.

About Health Research International (HRI)
Founded in 1978, HRI (www.healthri.com) provides the pharmaceutical and medical device industries with reliable, comprehensive, and meticulously researched market analysis that incorporates strategic vision and a thorough understanding of competing medical technologies. Quality, experience, and follow through have been the cornerstones of their custom consulting, online surveys, pricing sensitivity studies, FDA work, and market reports.

About Life Science Intelligence (LSI)®
LSI delivers high-quality market data and information to medical technology executives, entrepreneurs, and investors. LSI produces the EMT (Emerging Medical Technologies)® Database, medtech market reports, and provides global custom research services, including market assessments and physician surveys. In addition, LSI partners with top-tier information companies such as Health Research International (HRI) and Windhover/Medtech Insight to distribute their high-end information products. www.LSintelligence.com.

Contact:
Life Science Intelligence
Scott Pantel, 1 714 847 3540
scott@LSintelligence.com